Detalhe da pesquisa
1.
The impact of stereotactic ablative radiotherapy on oligoprogressive metastases from renal cell carcinoma.
J Cancer Res Clin Oncol
; 149(8): 4411-4417, 2023 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-36109401
2.
Total tumor volume as a predictor of survival in patients with multiple oligometastases treated with stereotactic ablative radiotherapy (SABR).
J Cancer Res Clin Oncol
; 149(12): 10495-10503, 2023 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-37280407
3.
Multimodal Treatments for Brain Metastases from Renal Cell Carcinoma: Results of a Multicentric Retrospective Study.
Cancers (Basel)
; 15(5)2023 Feb 22.
Artigo
Inglês
| MEDLINE | ID: mdl-36900186
4.
Locally Advanced Non-Small Cell Lung Cancer: Clinical Outcome, Toxicity and Predictive Factors in Patients Treated with Hypofractionated Sequential or Exclusive Radiotherapy.
Curr Oncol
; 29(7): 4893-4901, 2022 07 12.
Artigo
Inglês
| MEDLINE | ID: mdl-35877248
5.
Oligoprogressive castration-resistant prostate cancer treated with metastases-directed stereotactic body radiation therapy: predictive factors for patients' selection.
Clin Exp Metastasis
; 39(3): 449-457, 2022 06.
Artigo
Inglês
| MEDLINE | ID: mdl-35190933
6.
Training and validation of a knowledge-based dose-volume histogram predictive model in the optimisation of intensity-modulated proton and volumetric modulated arc photon plans for pleural mesothelioma patients.
Radiat Oncol
; 17(1): 150, 2022 Aug 26.
Artigo
Inglês
| MEDLINE | ID: mdl-36028862
7.
Stereotactic Body Radiation Therapy for Lung Metastases From Sarcoma in Oligometastatic Patients: A Phase 2 Study.
Int J Radiat Oncol Biol Phys
; 114(4): 762-770, 2022 11 15.
Artigo
Inglês
| MEDLINE | ID: mdl-35987453
8.
Stereotactic Body Radiation Therapy for Lung and Liver Oligometastases from Breast Cancer: Toxicity Data of a Prospective Non-Randomized Phase II Trial.
Curr Oncol
; 29(10): 7858-7867, 2022 10 17.
Artigo
Inglês
| MEDLINE | ID: mdl-36290898